Daptorum Group News Today

Has released an update. Aptorum Group, a biopharmaceutical company, has reported a decreased net loss of $4.3 million for the f...

Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced financial...

Aptorum Group Limited (NASDAQ:APM – Get Free Report) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 41,000 shares, a drop of 58.4% from the March 31st total of 98,500 shares. Currently, 1.9% of the company’s shares are short sold. […]

Aptorum Group Limited (NASDAQ:APM – Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 128,900 shares, an increase of 42,866.7% from the February 29th total of 300 shares. Based on an average daily volume of 2,310,000 shares, […]

Aptorum Group Limited (NASDAQ:APM – Get Free Report) was the target of a significant increase in short interest in January. As of January 31st, there was short interest totalling 3,800 shares, an increase of 81.0% from the January 15th total of 2,100 shares. Approximately 0.2% of the company’s shares are sold short. Based on an […]

Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases, today provided a business update and...

Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, announced the results of its...

Aptorum Group Limited (NASDAQ:APM – Get Free Report) saw a large decrease in short interest in October. As of October 31st, there was short interest totalling 19,000 shares, a decrease of 6.9% from the October 15th total of 20,400 shares. Currently, 1.5% of the shares of the company are sold short. Based on an average […]

Aptorum Group Limited (NASDAQ:APM – Get Free Report) was the target of a large drop in short interest in September. As of September 15th, there was short interest totalling 29,300 shares, a drop of 66.7% from the August 31st total of 88,000 shares. Currently, 2.3% of the company’s stock are sold short. Based on an […]

Aptorum Group Limited , a clinical-stage biopharmaceutical company, announced that it has received an approval letter from the Nasdaq Stock Market LLC Listing Qualifications Department notifying... -Today at 02:58 am- MarketScreener